FR09C0047I2 - Preparation de produits de recombinaison immunogenes au moyen d'hydrates de carbone solubles actives par l'intermediaire de reactifs organiques de cyanylation - Google Patents

Preparation de produits de recombinaison immunogenes au moyen d'hydrates de carbone solubles actives par l'intermediaire de reactifs organiques de cyanylation

Info

Publication number
FR09C0047I2
FR09C0047I2 FR09C0047C FR09C0047C FR09C0047I2 FR 09C0047 I2 FR09C0047 I2 FR 09C0047I2 FR 09C0047 C FR09C0047 C FR 09C0047C FR 09C0047 C FR09C0047 C FR 09C0047C FR 09C0047 I2 FR09C0047 I2 FR 09C0047I2
Authority
FR
France
Prior art keywords
carbonhydrates
immunogenic
soluble
activated
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR09C0047C
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henry M Jackson Found For T
Original Assignee
Henry M Jackson Found For T
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/408,717 external-priority patent/US5651971A/en
Priority claimed from PCT/US1996/004013 external-priority patent/WO1996029094A1/en
Publication of FR09C0047I1 publication Critical patent/FR09C0047I1/fr
Application filed by Henry M Jackson Found For T filed Critical Henry M Jackson Found For T
Application granted granted Critical
Publication of FR09C0047I2 publication Critical patent/FR09C0047I2/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
FR09C0047C 1995-03-22 2009-09-24 Preparation de produits de recombinaison immunogenes au moyen d'hydrates de carbone solubles actives par l'intermediaire de reactifs organiques de cyanylation Active FR09C0047I2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/408,717 US5651971A (en) 1993-09-22 1995-03-22 Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents
US48266195A 1995-06-07 1995-06-07
PCT/US1996/004013 WO1996029094A1 (en) 1995-03-22 1996-03-22 Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents

Publications (2)

Publication Number Publication Date
FR09C0047I1 FR09C0047I1 (enExample) 2009-06-11
FR09C0047I2 true FR09C0047I2 (fr) 2017-03-17

Family

ID=41360971

Family Applications (1)

Application Number Title Priority Date Filing Date
FR09C0047C Active FR09C0047I2 (fr) 1995-03-22 2009-09-24 Preparation de produits de recombinaison immunogenes au moyen d'hydrates de carbone solubles actives par l'intermediaire de reactifs organiques de cyanylation

Country Status (5)

Country Link
JP (1) JP5594612B2 (enExample)
KR (1) KR100417183B1 (enExample)
DE (2) DE122009000056I1 (enExample)
FR (1) FR09C0047I2 (enExample)
NL (2) NL300413I1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101635795B1 (ko) * 2009-12-17 2016-07-04 피나 바이오솔루션스, 엘엘씨 다당류/단백질 접합체 백신의 제조에 있어서 시안화제인 1-시아노벤조트리아졸 (1-cbt)을 통한 다당류의 활성화

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE343210B (enExample) * 1967-12-20 1972-03-06 Pharmacia Ab
US4496538A (en) * 1982-07-06 1985-01-29 Connaught Laboratories, Inc. Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine
DE3541186A1 (de) * 1985-11-21 1987-05-27 Boehringer Mannheim Gmbh Wasserloesliche, stabilisierte peroxidasederivate, verfahren zu ihrer herstellung und verwendung zur bestimmung von wasserstoffperoxid
IL96326A (en) * 1989-11-15 1995-07-31 Sandoz Ag Polymyxin conjugates, their preparation and pharmaceutical preparations containing them
EP0630260B1 (en) * 1991-03-12 2001-01-24 THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services Polysaccharide-protein conjugates
KR950700081A (ko) * 1992-02-11 1995-01-16 W 로우 죤 이중 캐리어 면역원성 구성물
EP0672053A1 (en) * 1992-12-07 1995-09-20 Magainin Pharmaceuticals Inc. Treatment of septic shock with conjugated biologically active peptides

Also Published As

Publication number Publication date
KR100417183B1 (ko) 2004-05-31
FR09C0047I1 (enExample) 2009-06-11
NL300413I1 (nl) 2009-12-01
JP2012116850A (ja) 2012-06-21
DE122009000056I1 (de) 2010-01-28
JP5594612B2 (ja) 2014-09-24
NL300414I1 (nl) 2009-12-01
KR19980703201A (ko) 1998-10-15
DE122009000055I1 (de) 2009-12-31

Similar Documents

Publication Publication Date Title
IL113817A0 (en) Polynucleotide vaccine for papillomavirus pharmaceutical compositions containing it and a method for its use
FR2817912B1 (fr) Reducteur reprenant les efforts axiaux generes par la soufflante d'un turboreacteur
EP0372466A3 (en) 2-amino-4 or 5-methoxycyclohexyl amides useful as analgesics
FI912820A7 (fi) Alumiinioksidiperustainen koostumus katalysaattoria varten ja menetelmä sen valmistamiseksi sekä katalysaattori ja sen valmistusmenetelmä
HUP9802199A1 (hu) Poliszacharid antigén-vivőprotein konjugátumot és szabad vivőproteint tartalmazó oltóanyag és alkalmazása
NO934122L (no) Peptid-nukleinsyrer
ES2181799T3 (es) Conjugados de acidos peptido nucleicos.
IT1283325B1 (it) Imballo per confezioni singole, nonche' procedimento e dispositivo per produrlo
NZ333226A (en) Immunstimulating lipid formulation
FI970247A7 (fi) Farmaseuttisia koostumuksia, jotka sisältävät kimeerisen TNF:ää sitova n proteiinin
FR09C0047I2 (fr) Preparation de produits de recombinaison immunogenes au moyen d'hydrates de carbone solubles actives par l'intermediaire de reactifs organiques de cyanylation
EE04398B1 (et) Asendatud 1,2,3,4,5,6-heksahüdro-2,6-metano-3-bensasotsiin-10-oolid, nende valmistamise meetod ja kasutamine ravimitena
HRP990341B1 (en) Process for the preparation of mometasone furoate
FR2645878B1 (fr) Sequences nucleotidiques d'actinomycetales, applications a la synthese ou a la detection d'acides nucleiques, produits d'expression de ces sequences et application en tant que compositions immunogenes
ES2165466T3 (es) Vacuna que comprende un virus atenuado de la enfermedad de newcastle.
HUP9802568A3 (en) Alkyl amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists and pharmaceutical compositions containing them
FR2693722B1 (fr) Dérivés de la N-cycloalkylpipérazine, procédé d'obtention et compositions pharmaceutiques les contenant.
RU97120940A (ru) Пептид, обладающий иммуномодулирующей активностью, и препарат на его основе
AU630186B2 (en) Canine corona virus vaccine
SE8704240L (sv) Analgetiska preparat
FR2731355B1 (fr) Nouveaux immunogenes, nouveaux anticorps, procede de preparation et compositions pharmaceutiques les renfermant
FR2582662B1 (fr) Nouvelles compositions a base de derives de silice modifiee par des groupements organiques, leur preparation et leur application
KR910009723A (ko) 4-카르바모일-1-β-D-리보푸라노실 이미다졸륨-5-올레이트 무수결정
IT1276509B1 (it) Vaccino per la profilassiimmunitaria dell'infezione da virus della immunodeficienza felina del gatto domestico.
FR2583049B1 (fr) Produits resultant de la conjugaison d'un support macromoleculaire, d'un haptene et d'un muramyl-peptide par l'intermediaire d'un groupement substituant la partie saccharidique du muramyl-peptide et compositions selectivement immunogenes contenant ces produits